The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.


Journal

Public health reports (Washington, D.C. : 1974)
ISSN: 1468-2877
Titre abrégé: Public Health Rep
Pays: United States
ID NLM: 9716844

Informations de publication

Date de publication:
Historique:
pubmed: 3 10 2019
medline: 20 2 2020
entrez: 3 10 2019
Statut: ppublish

Résumé

Opioid-related overdoses are commonly attributed to prescription opioids. We examined data on opioid-related overdose decedents in Massachusetts. For each decedent, we determined which opioid medications had been prescribed and dispensed and which opioids were detected in postmortem medical examiner toxicology specimens. Among opioid-related overdose decedents in Massachusetts during 2013-2015, we analyzed individually linked postmortem opioid toxicology reports and prescription drug monitoring program records to determine instances of overdose in which a decedent had a prescription active on the date of death for the opioid(s) detected in the toxicology report. We also calculated the proportion of overdoses for which prescribed opioid medications were not detected in decedents' toxicology reports. Of 2916 decedents with complete toxicology reports, 1789 (61.4%) had heroin and 1322 (45.3%) had fentanyl detected in postmortem toxicology reports. Of the 491 (16.8%) decedents with ≥1 opioid prescription active on the date of death, prescribed opioids were commonly not detected in toxicology reports, specifically: buprenorphine (56 of 97; 57.7%), oxycodone (93 of 176; 52.8%), and methadone prescribed for opioid use disorder (36 of 112; 32.1%). Only 39 (1.3%) decedents had an active prescription for each opioid detected in toxicology reports on the date of death. Linking overdose toxicology reports to prescription drug monitoring program records can help attribute overdoses to prescribed opioids, diverted prescription opioids, heroin, and illicitly made fentanyl.

Identifiants

pubmed: 31577519
doi: 10.1177/0033354919878429
pmc: PMC6832088
doi:

Substances chimiques

Analgesics, Opioid 0
Illicit Drugs 0
Heroin 70D95007SX
Fentanyl UF599785JZ

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

667-674

Subventions

Organisme : NIDA NIH HHS
ID : K23 DA042168
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358
pubmed: 29596405
J Anal Toxicol. 2016 Oct;40(8):588-594
pubmed: 27702938
JAMA. 2008 Dec 10;300(22):2613-20
pubmed: 19066381
J Addict Med. 2011 Sep;5(3):188-202
pubmed: 21844834
MMWR Morb Mortal Wkly Rep. 2017 Apr 14;66(14):382-386
pubmed: 28406883
Int J Drug Policy. 2017 Aug;46:172-179
pubmed: 28687187
Public Health Rep. 2018 Jul/Aug;133(4):423-431
pubmed: 29945473
BMJ. 2013 Jan 30;346:f174
pubmed: 23372174
J Med Toxicol. 2012 Dec;8(4):408-16
pubmed: 23180358
J Pain Palliat Care Pharmacother. 2015 Jun;29(2):133-9
pubmed: 26095483
Forensic Sci Med Pathol. 2016 Sep;12(3):243-7
pubmed: 27114260
Pain Med. 2018 Mar 1;19(3):511-523
pubmed: 28340233
Addiction. 2009 Sep;104(9):1541-8
pubmed: 19686524
Am J Emerg Med. 2016 Mar;34(3):510-4
pubmed: 26778639
Drug Alcohol Depend. 2017 May 1;174:58-64
pubmed: 28315808
Addiction. 2018 Jul;113(7):1339-1344
pubmed: 29430760
J Gen Intern Med. 2010 Apr;25(4):305-9
pubmed: 20087676
Drug Alcohol Depend. 2017 Dec 1;181:44-49
pubmed: 29032024
Public Health Rep. 2015 Jul-Aug;130(4):339-42
pubmed: 26345488
JAMA Intern Med. 2014 May;174(5):796-801
pubmed: 24589873
J Med Toxicol. 2014 Mar;10(1):100-6
pubmed: 24132519
Pain Med. 2014 Jul;15(7):1187-95
pubmed: 25202775
MMWR Morb Mortal Wkly Rep. 2011 Nov 4;60(43):1487-92
pubmed: 22048730
Drug Alcohol Depend. 2018 Sep 1;190:62-71
pubmed: 29981943
J Subst Abuse Treat. 2016 Jan;60:6-13
pubmed: 26233698
MMWR Morb Mortal Wkly Rep. 2016 Dec 30;65(50-51):1445-1452
pubmed: 28033313
Addict Behav. 2017 May;68:35-38
pubmed: 28088741
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):844-9
pubmed: 27560948
BMJ. 2017 Apr 26;357:j1550
pubmed: 28446428
MMWR Morb Mortal Wkly Rep. 2017 Jul 07;66(26):697-704
pubmed: 28683056
Int J Drug Policy. 2017 Aug;46:136-145
pubmed: 28578864
MMWR Morb Mortal Wkly Rep. 2016 Aug 26;65(33):837-43
pubmed: 27560775

Auteurs

Alexander Y Walley (AY)

Department of Medicine, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA, USA.
Massachusetts Department of Public Health, Boston, MA, USA.

Dana Bernson (D)

Massachusetts Department of Public Health, Boston, MA, USA.

Marc R Larochelle (MR)

Department of Medicine, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston University School of Medicine & Boston Medical Center, Boston, MA, USA.

Traci C Green (TC)

Department of Emergency Medicine, Injury Prevention Center, Boston University School of Medicine & Boston Medical Center, Boston, MA, USA.

Leonard Young (L)

Massachusetts Department of Public Health, Boston, MA, USA.

Thomas Land (T)

Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH